NeuroScientific appoints top doctor ahead of stem cell therapy rollout
The hire has come at a critical time as the company accelerates the development of its recently acquired StemSmart technology. StemSmart uses a specific type of stem cell, mesenchymal stromal stem cells (MSC), as a last-line infusion treatment for critically ill patients, including those experiencing severe immune complications from bone marrow transplants, kidney and lung transplant rejection and the inflammatory Crohn's disease.
The company expects later this year to receive the interim results from its latest compassionate trial involving patients with difficult-to-treat fistulising Crohn's disease, in which an open wound develops from a gut flare-up that extends out to the skin.
A successful trial will help the company validate its proprietary StemSmart technology in this patient group, who otherwise have limited treatment options.
'Cathy's vast experience and leadership will greatly strengthen our management team.'
Neuroscientific Biopharmaceuticals chairman Rob McKenzie
Cole brings extensive experience to the table, having held clinical and academic leadership roles across Australia and overseas, including head of haematology and oncology at Perth Children's Hospital and professor of paediatric haematology and oncology at The University of Western Australia.
She is also director of stem cell transplantation at Perth Children's Hospital, placing her front and centre in NeuroScientific's race to employ stem cell therapy to treat some of the most debilitating transplant complications and autoimmune diseases.
The seasoned physician has additionally served on ethics committees and worked closely with national and international regulators, a skillset the company hopes will prove instrumental as it seeks regulatory approvals for StemSmart in Australia and abroad.
NeuroScientific Biopharmaceuticals chairman Rob McKenzie said: ' We are very fortunate that Cathy is joining at this key time in the company's evolution. Her vast experience and leadership will greatly strengthen our management team as we progress our SAS fistulas in Crohn's program and make plans for future growth.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sydney Morning Herald
3 hours ago
- Sydney Morning Herald
Does Australia's biggest contribution to global dining come from ... McDonald's?
Before flat whites surged through New York City, Aussie-inspired coffee was being poured at America's first McCafe in Chicago, back in 2001. Since its Melbourne creation in 1993, the McDonald's concept has taken off globally and McCafes now serve macarons in France and alfajores in Argentina. There are McCafes with bubble tea in China, zaatar croissants in Saudi Arabia and local coffee beans in Guatemala. 'I don't think it would be crazy to argue that Australian coffee culture is the country's biggest culinary contribution to the world, within which McCafe plays a major role as the delivery vehicle,' says Gary He, author of McAtlas: A Global Guide to the Golden Arches. The self-published book won the Reference, History and Scholarship category at the prestigious James Beard food media awards in June, held in Chicago. He, a US-based writer and photographer, travelled to McDonald's outlets across six continents to document the fast-food chain's surprising diversity. The project, started in 2018, has taken him to more than 50 countries, from Sweden's McSki to Germany's McBoat and New Zealand's Taupo location which incorporates an actual plane.
Sydney Morning Herald
3 hours ago
- Sydney Morning Herald
‘Private placements', property and cars: Inside WA's multimillion-dollar fraud trial
The first week of the trial of an alleged Perth-based fraudster heard his former clients claimed they had no idea he was hedging their investments with real estate and cars, rather than keeping the funds safe in a 'blocked bank account'. Private investor Chris Marco is on trial in West Australia's Supreme Court, facing 44 charges after allegedly defrauding investors of about $36.4 million. His former executive assistant, Linda Marissen, has been charged with 30 offences for her alleged role in the crimes. Both have pleaded not guilty to all charges. The minimum investment to work with Marco was $100,000, and his clients included an environmental scientist and a Sydney-based insurance underwriter. In his opening statement, Prosecutor Steven Whybrow said Marco spent years developing credibility with his clients between 2011 and 2018, promising to invest their money in lucrative overseas investment structures called 'private placements'. Private placements are when a company raises money by selling shares, bonds, or securities to a select group of private investors, rather than through the public stock exchange. They are generally a riskier type of investment and aimed at exclusive groups of people, which Marco claimed to have access to. In an interview from 2021 played to the court on Friday, Marco said he mainly ran them through overseas operators. Whybrow told the court Marco added to his credibility by allowing investors to pull their money out at any time, but the generous returns his clients received meant they often rolled over their investments.
The Age
3 hours ago
- The Age
‘Private placements', property and cars: Inside WA's multimillion-dollar fraud trial
The first week of the trial of an alleged Perth-based fraudster heard his former clients claimed they had no idea he was hedging their investments with real estate and cars, rather than keeping the funds safe in a 'blocked bank account'. Private investor Chris Marco is on trial in West Australia's Supreme Court, facing 44 charges after allegedly defrauding investors of about $36.4 million. His former executive assistant, Linda Marissen, has been charged with 30 offences for her alleged role in the crimes. Both have pleaded not guilty to all charges. The minimum investment to work with Marco was $100,000, and his clients included an environmental scientist and a Sydney-based insurance underwriter. In his opening statement, Prosecutor Steven Whybrow said Marco spent years developing credibility with his clients between 2011 and 2018, promising to invest their money in lucrative overseas investment structures called 'private placements'. Private placements are when a company raises money by selling shares, bonds, or securities to a select group of private investors, rather than through the public stock exchange. They are generally a riskier type of investment and aimed at exclusive groups of people, which Marco claimed to have access to. In an interview from 2021 played to the court on Friday, Marco said he mainly ran them through overseas operators. Whybrow told the court Marco added to his credibility by allowing investors to pull their money out at any time, but the generous returns his clients received meant they often rolled over their investments.
